Pharma goes small for process improvement; Study links supply chain analytics with margin;

> Big spending by drugmakers on new facilities is giving way to a focus on manufacturing processes by, in part, using scalable technologies that allow for smaller, highly targeted projects. Story

> Drugmakers indicating stronger analytical capabilities (e.g., closer integration with customers on demand forecasting) also consistently demonstrate higher margins, in a recent study. Article

> The $150-million cleanup of manufacturing wastes and wastewater treatment residuals at a 78-acre Connecticut site formerly occupied by Pharmacia & Upjohn will restore wetlands and meadow habitat. Story

> Last week marked the launch of the Engineering and Physical Sciences Research Council Centre for pharma and chemical production, which aims to develop more effective and sustainable methods of manufacturing, being led by the University of Strathclyde in Glasgow. Article

> Johnson & Johnson has tapped pharmaceuticals division exec Denise Torres to lead the troubled McNeil Consumer division. Story

> Brand Index is an information service that will identify and track major providers of specific CMO services (e.g., product formulation, lyophilization, fill/finish) Story

> Jeremy Shultz, a 23-year-old convicted of abducting and robbing a pharmaceutical deliveryman in Charleston, WV, will spend at least 31 years in prison. Story

> A Brit will spend the next eight years behind bars for supplying more than 2 million doses of counterfeit drugs into the European supply chain. Story

Suggested Articles

Lonza CEO Marc Funk is leaving for "personal reasons" after less than a year in the top job. 

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.